ProPhase Labs, Inc.
PRPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $190,258 | $162,425 | $77,079 | $154,905 |
| - Cash | $405 | $169 | $88 | $678 |
| + Debt | $7,684 | $7,866 | $14,007 | $24,573 |
| Enterprise Value | $197,537 | $170,122 | $90,998 | $178,800 |
| Revenue | $883 | $1,247 | $1,431 | -$2,484 |
| % Growth | -29.2% | -12.9% | 157.6% | – |
| Gross Profit | -$123 | $734 | $526 | $924 |
| % Margin | -13.9% | 58.9% | 36.8% | -37.2% |
| EBITDA | -$4,392 | -$3,566 | -$2,536 | -$14,317 |
| % Margin | -497.4% | -286% | -177.2% | 576.4% |
| Net Income | -$6,839 | -$4,472 | $3,966 | -$34,359 |
| % Margin | -774.5% | -358.6% | 277.1% | 1,383.2% |
| EPS Diluted | -1.6 | -1.1 | 2.1 | -15.8 |
| % Growth | -45.5% | -152.4% | 113.3% | – |
| Operating Cash Flow | -$21,523 | -$247 | -$3,381 | $2,164 |
| Capital Expenditures | $0 | $0 | $0 | $235 |
| Free Cash Flow | -$21,523 | -$247 | -$3,381 | $2,399 |